Strs Ohio Lexicon Pharmaceuticals, Inc. Transaction History

Strs Ohio

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 22, 2021	SELL	$3.38 - $5.35 $53,066 - $83,995	-15,700 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$4.12 - $5.87 $424,772 - $605,197	-103,100 Reduced 86.78%	15,700 $72,000
Q1 2021 Apr 23, 2021	SELL	$3.45 - $9.09 $297,045 - $782,649	-86,100 Reduced 42.02%	118,800 $697,000
Q4 2020 Jan 25, 2021	SELL	$1.05 - $3.67 $113,820 - $397,828	-108,400 Reduced 34.6%	204,900 $700,000
Q3 2020 Dec 14, 2020	BUY	$1.44 - $2.1 $115,344 - $168,210	80,100 Added 34.35%	313,300 $451,000
Q2 2020 Jul 23, 2020	BUY	$1.75 - $2.3 $123,200 - $161,920	70,400 Added 43.24%	233,200 $465,000
Q1 2020 Apr 23, 2020	BUY	$1.8 - $4.28 $61,020 - $145,092	33,900 Added 26.3%	162,800 $317,000
Q4 2019 Jan 24, 2020	BUY	$3.16 - $5.15 $407,324 - $663,835	128,900 New	128,900 $534,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.